The 2012 US Infectious Disease Testing Market

NEW YORK, April 18, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

The 2012 US Infectious Disease Testing Market

http://www.reportlinker.com/p0368579/The-2012-US-Infectious-Disease-Testing-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

This report presents a comprehensive analysis of the US infectious disease testing market, including:

• Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
• Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorganisms.
• Ten-year test volume and sales forecasts for nearly 80 infectious disease testing performed in US hospitals, blood banks, physician offices, public health and commercial laboratories.
• Instrumentation technologies and feature comparison of leading analyzers.
• Sales and market shares of leading suppliers.
• Emerging diagnostic technologies and their potential market applications.
• Product development opportunities.
• Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
• Business opportunities and strategic recommendations for suppliers.

Contains 1,037 pages and 177 tables

Table of Contents

Introduction

Worldwide Market and Technology Overview

A. Major Infectious Disease Tests

1. AIDS

a. Background

Structure and Composition

Classification

Origin of AIDS

Animal Lentivirus Systems

Virus Receptos

HIV Infections in Humans

- Pathogenesis & Pathology: Overview of

HIV Infection Course

CD4T Lymphocytes and Memory Cells

Monocytes and Macrophages

Lymphoid Organs

Neural Cells

Viral Coinfections

- Clinical Findings

Plasma Viral Load

Pediatric AIDS

- Neurologic Disease

- Opportunistic Infections

- Cancer

Immunity

- Virus Isolation

- Serology

- Detection of Viral Nucleic

Acid and Antigens

Infectivity

Epidemiology

- Worldwide Spread of AIDS

- United States

- Routes of Transmission

b. Diagnostic Tests

Laboratory Diagnosis

- Enzyme Immunoassay Interpretation

- Specific, Sensitivity, and Predictive

Value of Enzyme Immunoassays

Competition Assays

Western Blot Technique

Immuno-Fluorescence Assay (IFA)

Radioimmunoprecipitation

HIV-1/HIV-2 Combination Testing

Methods of HIV-Antigen Detection

Antigen Assays and Blood Screening

Urine Tests

Immunopathogenic Mechanism of HIV Infection

DNA Probes

- Overview

- Quantitative Polymerase Chain Reaction

- In Situ PCR

- Needed Improvements

Viral Load/Drug Resistance Testing

Genotype and Phenotype Testing

Blood Banking Consideration

c. Vaccines and Drugs

- Antiviral Drugs

- Vaccines Against HIV

Transmission of HIV in Blood Products

HIV Transmission in Transplant and

Artificial Insemination Recipients

2. Adenovirus

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

d. Adeno-Associated Viruses(AAV)

3. Aeromonas

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

4. Anthrax/Bacillus Anthracis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

5. Arboviruses

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

6. Babesiosis

a. Background

7. Bacillary Epithelioid Angiomatosis (BEA)

And Other Bartonella (Rochalimaea)

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

8. Blastocystis Hominis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

9. Brucella

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

10. Campylobacter

a. Background

b. Diagnostic Tests

Identification from Culture

c. Vaccines and Drugs

11. Candida

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

12. Chagas Disease

a. Background

13. Chancroid

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

14. Chlamydia

a. Background

Chlamydia Psittaci

Chlamydia Pneumoniae

Chlamydia Trachomatis

b. Diagnostic Tests

c. Vaccines and Drugs

15. Clostridium Difficile

a. Background

Pediatric Infections

Epidemiology

b. Diagnostic Tests

Counterimmunoelectrophoresis

Fluorescent-Antibody Assays

Poloymerase Chain Reactions

c. Drugs and Vaccines

16. Coronaviruses

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

17. Coxsackieviruses

a. Background

Herpangina

Hand-foot-and-mouth syndrome

Hepidemic Conjuctivitis

Pharingitis

Epidemic Pleurodynia

Myodarditis,Pericarditis

Overwhelming Infection of the Newborn

Acute Aseptic Meningitis

Undifferentiated Febrile Illness

Fever with upper respiratory infection

Encephalitis

Asymptomatic Infection

b. Diagnostic Tests

c. Vaccines and Drugs

18. Creutzfeldt-Jakob's Disease

a. Background

Blood Transmission

b. Diagnostic Tests

Major Commercial and Academic Players

- Bayer

- Disease Sciences/Bio Tec Global

- Imperial College of Medicine

- Ortho-Clinical Diagnostics

- Pall

- ProMetic Life Sciences

- Proteome Sciences/Idexx

- Q-One Biotech

- Serono

- U.S. Agricultural Research Service

c. Vaccines

19. Cryptosporidium Parvum

a. Background

b. Diagnostic Tests

Histologic

Laboratory Parasitology

Serodiagnosis

c. Vaccines and Drugs

20. Cyclospora Cayetanensis

a. Background

Asymptomatic Infection

Diarrhea in Immunocompetent Persons

Diarrhea in Immunocompromisedersons

b. Diagnostic Tests

c. Vaccines and Drugs

21. Cytomegalovirus

a. Background

Chorioretinitis

Gastrointestinal

Central Nervous System Disease

b. Diagnostic Tests

c. Vaccines and Drugs

22. Ebola Virus

a. Background

Epidemiology

Hemorrhagic Fever

b. Diagnostic Tests

c. Vaccines and Drugs

23. E. Coli

a. Background

Role of Escherichia Coli in

Causing Diarrhea

EPEC

ETEC

EIEC

EHEC

b. Diagnostic Tests

c. Vaccines and Drugs

24. EchoVirus

a. Background

Acute Aseptic Miningitisis

Encephalitis

Exanthems

Respiratory Disease

Myope;ricarditis

Neonatal Infections

b. Diagnostic Tests

c. Vaccines and Drugs

25. Encephalitis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

26. Enteroviruses

a. Background

b. Diagnostic Tests

Viral Isolation and Identification

Antibody Tests

c. Vaccines and Drugs

27. Epstein-Barr Virus

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

28. Giardia Lamblia

a. Background

Life Cycle and Morphology

Morphology of Trophozoites

Clinical Disease

b. Diagnostic Tests

c. Vaccines and Drugs

29. Gonorrhea

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

30. Granuloma Inguinale

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

31. Hantavirus

a. Background

Identification of the Agent

Transmission

Other Rodent Hantaviruses

Distribution

Hantavirus Diseases

Epidemiology

Addendum in Proof-Northeastern Connection

Previously Unknown Pathogens

Cases Nationwide

b. Diagnostic Tests

An Immunohistochemistry Approach

Hantavirus Rapid Diagnostic Test

ELISA Diagnosis of Hantavirus Pulmonary

Syndrome

IgG ELISA

IgM Capture ELISA

c. Vaccines and Drugs

32. Helicobacter Pylori

a. Background

Pathogenesis

Role in Peptic Ulcer Disease

Role in Gastric Cancer

Nonulcer Dyspepsia

b. Diagnostic Tests

c. Vaccines and Drugs

Specific Therapeutic Regimens

Who Should Be Treated?

Participants in Controlled Clinical Trials

Patients with Refractory Peptic Ulcer

Patients with Refractory NUD

Patients in High-Risk Groups for Gastric

Cancer

33. Hepatitis

a. Background

b. Hepatitis A

c. Hepatitis B

d. Hepatitis C

Classification

Transmission of Infection

Occupational Hazards

Acute Hepatitis

Diagnosis of Acute Infection

Chronic Hepatitis

HCV and Other Chronic Liver Diseases

Alcoholic Liver Disease

Hepatitis B Coinfection

Cirrhosis and Hepatocellular Carcinoma

Diagnostic Tests

Possible Indications for HCV RNA Testing

Conclusions and Future Direction

e. Hepatitis D

Historical Perspective

Epidemiology

HBV-HDV "Coinfection" vs. "Superinfection"

Methods of Detecting HDV

Prevention

f. Hepatitis E

Background

Prevalence of the Disease

Diagnostic Tests

Epidemiologic Serosurveys

Serologic Cross-Reactivity

g. Hepatitis G

Vaccines and Drugs

34. Herpes Simplex Virus

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

35. Human Herpes Virus-6 (HHV-6)

a. Background

HIV-6 Infections

b. Diagnostic Tests

c. Vaccines and Drugs

36. Influenza Viruses

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

37. Legionella

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

38. Lyme Disease

a. Background

Clinical Description

Clinical Case Definition

Laboratory Criteria for Diagnosis

Case Classification

b. Diagnostic Tests

c. Vaccines and Drugs

39. Lymphogranuloma Venereum (LGV)

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

40. Malaria

a. Background

b. Diagnostic Tests

Potential Diagnositic Problems with Positive

Patients from Non-endemic Areas

- Patient

- Laboratory

- Physician

c. Vaccines and Drugs

41. Measles (Rubeola)

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

42. Meningitis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

Development of Polysaccharide Vaccines

Quadrivalent Vaccine Development

Meningococcal A.C.Y. & W-135 Vaccines

Efficacy of Group C Vaccine

Efficacy of Group A Vaccine

Combinations of Group A and C Vaccines

Group B Efficacy Trials

Future Direction

43. Microsporidium

a. Background

Prevalence and Geographic Distribution

Sources of Human Infection and Transmission

b. Diagnostic Tests

Light Microscopic Examination of Stool

Specimens By Chromotrope Staining

Stool Concentration Methods

Chemofluorescent Agents

Giemsa Staining of Stool Specimens

Cytologic Diagnosis

Histologic Examination

Electron Microscopy

Examination of Bodily Fluids

Examination of Tissue Sections

Immunofluorescence Detection Procedures

Serology

Cell Culture

Approach to Diagnosis

Evaluation of Patients with Presumptive

Intestinal Microsporidiosis

Evaluation of Patients with Presumptive

Ocular Microsporidiosis

c. Vaccines and Drugs

44. Mononucleosis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

45. Mumps

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

Efficacy of Vaccination

Future Issues

46. Mycoplasma

a. Background

Ureaplasma Urealyticum & Mycoplasma Hominis

b. Diagnostic Tests

c. Vaccines and Drugs

47. Papillomaviruses

a. Background

HPV in Cancer

Cervical Neoplasm

b. Diagnostic Tests

c. Vaccines and Drugs

Prevention

48. Parvovirus B19

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

49. Pneumonia

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

50. Polyomaviruses

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

51. Pseudomonas Aeruginosa

a. Background

Virulence Factors

b. Diagnostic Tests

c. Vaccines and Drugs

52. Rabies

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

53. Respiratory Syncytial Virus (RSV)

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

54. RhinoViruses

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

55. RotaVirus (REOVIRUS)

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

56. Rubella(MEASLES)

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

Developing Countries

Elimination and Eradication of Measles

New Developments

57. Salmonellosis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

58. Septicemia

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

59. Shigellosis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

60. Staphylococcus Aureus

a. Background

The Genus Taphylococcus

b. Diagnostic Tests

c. Vaccines and Drugs

Prevention

61. Streptococci

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

Group A Streptococci

Group B Streptococci

62. Syphilis

a. Background

b. Diagnostic Tests

Biopsy

Rabbit Infectivity Testing

Other Diagnostic Modalities

c. Vaccines and Drugs

Syphilis and HIV Infection

Syphilis As a Cofactor for HIV Transmission

Basic Science Issues

63. Toxoplasmosis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

64. Trichomonas Vaginalis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

65. Tuberculosis

a. Background

b. Diagnostic Tests

Microscopic Characteristics

Cultural Characteristics

Detection of Antibodies

Skin Tests

MDRTB

c. Vaccines and Drugs

66. Vibrio

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

67. West Nile Virus

a. Background

- Clinical Syndromes

b. Diagnostic Tests

c. Vaccines and Drugs

68. Yersina

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

B. Instrumentation Review and Market Needs

Abbott AxSYM

Abbott IMx/IMx Select

Anagen AN2000/AuraFlex

Siemens Immuno 1

Beckman Coulter Access

BioChem Pharma/SR1

BioMerieux/Vitek Vidas

Biotrol System 7000

Chiron ACS: Centaur

Chiron ACS: 180

Siemens ELISA Processor II/III

Siemens/Opus/Plus/Magnum

Siemens Stratus

J&J Diagnostics Vitros ECi

J&J Diagnostics/Amersham Amerlite

Olympus PK310

Roche Elecsys 1010/2010

Roche Cobas Core

Roche ES 300/300AL

Roche ES 22

Roche ES 33

Tosoh AIA-1200/1200DX/NexIA/600

Wallac/Pharmacia Delfia

C. Emerging Diagnostic Technologies

1. DNA Probes

a. Technology Overview

b. Amplification Methods

Polymerase Chain Reaction

- Robotics

- Temperature Cyclers

- PCR Variations

Immuno-PCR

QC-PCR

DAP-PCR

Ligase Chain Reaction

Branched DNA

Q-Beta Replicase

Nucleic-Acid Sequence-Based

Strand Displacement Activation

Self-Sustained Sequence Replicase

2. Monoclonal Antibodies

3. Immunoassays

a. Technological Principle

b. Enzyme Immunoassays (EIA)

Overview

ELISA

Dot Immunobinding Assays

Capillary Immunoassays

Particle-Membrane Capture

Immunoassays

Enzyme Amplification

c. Fluorescent Immunoassays

Fluorescence Polarization

Time-Resolved Pulse Fluorescence

d. Luminescence

Chemiluminescence

Bioluminescence

e. Latex Agglutination

f. Immunoprecipitation

4. Differential Light Scattering

5. Microcomputers and Automation

6. Artificial Intelligence

7. Liposomes

8. Flow Cytometry

9. Chromatography

10. MRI

11. Gel Microdroplets

12. Other

D. Personal Testing

E. Worldwide Business Environment

F. Worldwide Market Structure

G. Worldwide Market Size and Growth

U.S.A.

A. Executive Summary

B. Business Environment

1. Health Care Expenditures

2. Cost Consciousness

3. Reimbursement

4. Industry Consolidation

5. Managed Care

a. HMO

b. PPO

6. Hospitals

7. Admissions

8. Length of Stay

9. Industry Diversification

10. Physician Demographics

11. Population Aging

a. Chronic Illness

b. Disease Incidence

c. Susceptibility to Iatrogenesis

d. Multiple Illness Cases

12. Laboratory Regulations

13. FDA Reform

C. Market Structure

1. Centralized Testing

a. Hospitals

b. Commercial/Private Laboratories

c. Blood Banks

1) Community and Regional Centers

2) Plasma Fractionation Centers

2. Decentralized Testing

a. Physician Offices/Group Practices

b. Point of Care Testing

c. Other Decentralized Testing Locations

D. Market Size, Growth and Major Suppliers

Major Product Development Opportunities

A. Instrumentation

B. Reagent Kits and Test Systems/Panels

C. Computers, Software and Automation

D. Auxiliary Products

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies

A. Internal Development

B. Collaborative Arrangements

C. University Contracts

D. Distribution Strategies for Decentralized

Testing Markets

1. Marketing Approaches

2. Product Complexity

3. Customer Preference

4. Established Suppliers

5. Emerging Suppliers

6. Major Types of Distributors

7. Market Segmentation

Potential Market Entry Barriers and Risks

A. Market Maturity

B. Cost Containment

C. Competition

D. Technological Edge and Limitations

E. Patent Protection

F. Regulatory Constraints

G. Decentralized Testing Market Challenges

Competitive Assessments

- Abbott

- Affymetrix

- Applera

- Beckman Coulter

- Becton Dickinson

- Binding Site

- Biomerica

- Biokit

- bioMerieux

- Bio-Rad

- Biotrol

- Biosite

- Biotest

- Caliper Technologies

- Cepheid

- Chemicon

- Daiichi

- DiaSorin

- Diagast

- Diamedix

- Digene

- Eiken

- Enzo Biochem

- Fujirebio

- GenBio

- Gene-Tec

- Hemagen

- Immunetics

- Innogenetics

- Inverness

- J&J

- Meridian

- Nanogen

- Nissui

- Olympus

- Provalis

- Roche

- Saliva Diagnostic

- SeraCare

- Siemens

- Third Wave Technologies

- Thermo Fisher

- Tosho

- Trinity Biotech

- Tropix

- Wampole Labs

- Zenith

- Zeus

Appendix: Assumed Currency Exchange Rates

List of Tables

Major Companies Developing or Marketing AIDS Tests

Major Companies Developing or Marketing Adenovirus

Tests

Major Companies Developing or Marketing Bartonella

Tests

Major Companies Developing or Marketing

Campylobacter Tests

Major Companies Developing or Marketing Candida

Tests

Major Companies Developing or Marketing Chlamydia

Tests

Major Companies Developing or Marketing Clostridium

Tests

Major Companies Developing or Marketing Coronavirus

Tests

Major Companies Developing or Marketing Cryptosporidium

Tests

Major Companies Developing or Marketing CMV Tests

Major Companies Developing or Marketing Echovirus

Tests

Major Companies Developing or Marketing Enterovirus

Tests

Major Companies Developing or Marketing EBV Tests

Major Companies Developing or Marketing Giardia

Tests

Major Companies Developing or Marketing Gonorrhea

Tests

Major Companies Developing or Marketing Hantavirus

Tests

Major Companies Developing or Marketing Helicobacter

Pylori Tests

Major Companies Developing or Marketing Hepatitis

Tests

Major Companies Developing or Marketing Herpes

Tests

Major Companies Developing or Marketing Influenza

Tests

Major Companies Developing or Marketing Legionella

Tests

Major Companies Developing or Marketing Lyme Disease

Tests

Major Companies Developing or Marketing Lymphogranuloma

Tests

Major Companies Developing or Marketing Malaria

Tests

Major Companies Developing or Marketing Measles

Tests

Major Companies Developing or Marketing Meningitis

Tests

Major Companies Developing or Marketing Microsporidium

Tests

Major Companies Developing or Marketing

Mononucleosis Tests

Major Companies Developing or Marketing Mumps Tests

Major Companies Developing or Marketing Mycoplasma

Tests

Major Companies Developing or Marketing Papilloma

Virus Tests

Major Companies Developing or Marketing Parvovirus

Tests

Major Companies Developing or Marketing Pneumonia

Tests

Major Companies Developing or Marketing RSV Tests

Major Companies Developing or Marketing Rotavirus

Tests

Major Companies Developing or Marketing Rubella

Tests

Major Companies Developing or Marketing Salmonella

Tests

Major Companies Developing or Marketing Septicemia

Tests

Major Companies Developing or Marketing Shigella

Tests

Major Companies Developing or Marketing Staphylococci

Tests

Major Companies Developing or Marketing

Streptococci Tests

Major Companies Developing or Marketing Syphilis

Tests

Major Companies Developing or Marketing Toxoplasmosis

Tests

Major Companies Developing or Marketing Trichomonas

Tests

Major Companies Developing or Marketing Tuberculosis

Tests

Major Companies Developing or Marketing West Nile

Tests

Major Companies Developing or Marketing Yersinia Tests

Worldwide All Market Segments Laboratories

Performing Infectious Disease Tests by

Country

Worldwide All Market Segments Total Infectious

Disease Test Volume Forecast by Country

Worldwide All Market Segments Total Infectious

Disease Diagnostics Market Forecast by Country

Infectious Disease Tests Major Issues and Market

Potential For Personal Testing

U.S.A. Summary Table

All Infectious DiseasesTest Volume and Diagnostics

Sales Forecast by Market Segment

U.S.A.

Laboratories Performing Infectious Disease Tests

by Market Segment

U.S.A.

Hospital Laboratories Performing Infectious Disease

Tests by Bed Size

U.S.A.

Commercial/Private Laboratories Performing Infectious

Disease Tests by Annual Test Volume

U.S.A.

Physician Office Laboratories Performing Infectious

Disease Tests by Practice Size

U.S.A.

All Market Segments Infectious Disease Test Volume Forecast

U.S.A.

Hospital Laboratories Infectious Disease Test Volume Forecast

U.S.A.

Blood Banks Infectious Disease Test Volume Forecast

U.S.A.

Physician Office Laboratories Infectious Disease

Test Volume Forecast

U.S.A.

Commercial/Private Laboratories Infectious Disease

Test Volume Forecast

U.S.A.

Public Health Laboratories Infectious Disease Test

Volume Forecast

U.S.A.

All Market Segments Infectious Disease Diagnostics

Market Forecast

U.S.A.

Hospital Laboratories Infectious Disease Diagnostics

Market Forecast

U.S.A.

Blood Banks Infectious Disease Diagnostics Market Forecast

U.S.A.

Physician Office Laboratories Infectious Disease

Diagnostics Market Forecast

U.S.A.

Commercial/Private Laboratories Infectious Disease

Diagnostics Market Forecast

U.S.A.

Public Health Laboratories Infectious Disease

Diagnostics Market Forecast

U.S.A.

HIV or HIVI/hIVII Test Volume and Diagnostics Sales

Forecast by Market Segment

U.S.A.

HTLV I or HTLV I/HTLV II Test Volume and Diagnostics

Sales Forecast by Market Segment

U.S.A.

HIVAg Test Volume and Diagnostics Sales Forecast by Market

Segment

U.S.A.

Western Blot/Other Confirmatory Test Volume and

Diagnostics Sales Forecast by Market Segment

U.S.A.

Adenovirus Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

Aeromonads Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

BEA Test Volume and Diagnostics Sales Forecast by Market

Segment

U.S.A.

Blastocystis Hominis Test Volume and Diagnostics Sales

Forecast by Market Segment

U.S.A.

Campylobacter Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

Candida Test Volume and Diagnostics Sales Forecast by Market

Segment

U.S.A.

Chancroid Test Volume and Diagnostics Sales Forecast by Market

Segment

U.S.A.

Chlamydia Test Volume and Diagnostics Sales Forecast by Market

Segment

U.S.A.

Clostridium Test Volume and Diagnostics Sales Forecast by

Market

Segment

U.S.A.

Coronavirus Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

Cryptosporidium Test Volume and Diagnostics Sales

Forecast by Market Segment

U.S.A.

CMV Test Volume and Diagnostics Sales Forecast by Market

Segment

U.S.A.

E. Coli Test Volume and Diagnostics Sales Forecast by Market

Segment

U.S.A.

Echovirus Test Volume and Diagnostics Sales Forecast by Market

Segment

U.S.A.

Enterovirus Test Volume and Diagnostics Sales Forecast by

Market

Segment

U.S.A.

EBV Test Volume and Diagnostics Sales Forecast by Market

Segment

U.S.A.

Giardia Test Volume and Diagnostics Sales Forecast by Market

Segment

U.S.A.

Gonorrhea Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

Granuloma Inguinale Test Volume and Diagnostics

Sales Forecast by Market Segment

U.S.A.

Hantavirus Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

Helicobacter Pylori Test Volume and Diagnostics

Sales Forecast by Market Segment

U.S.A.

HBsAg

Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Hepatitis C Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

Anti-HBC Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

Anti-HBS Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

Anti-HAV Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

Hepatitis Delta Test Volume and Diagnostics Sales

Forecast by Market Segment

U.S.A.

HBcAg Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

HBeAg Test Volume and Diagnostics Sales Forecast by Market

Segment

U.S.A.

ALT/SGPT Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

Herpes Simplex I and II Test Volume and Diagnostics

Sales Forecast by Market Segment

U.S.A.

Herpes Type VI Test Volume and Diagnostics Sales

Forecast by Market Segment

U.S.A.

Influenza Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

Legionella Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

Lyme Disease Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

Lymphogranuloma Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

Malaria Test Volume and Diagnostics Sales Forecast by Market

Segment

U.S.A.

Measles Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

Meningitis Test Volume and Diagnostics Sales Forecast by

Market

Segment

U.S.A.

Microsporidium Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

Mononucleosis Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

Mumps Test Volume and Diagnostics Sales Forecast by Market

Segment

U.S.A.

Mycoplasma Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

Papilloma Virus Test Volume and Diagnostics Sales

Forecast by Market Segment

U.s.a.

Parvovirus Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

Pneumonia Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

Poliomaviruses Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

Pseudomonas Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

Rabies

Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Rsv

Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Rheumatoid Arthritis Test Volume And Diagnostics

Sales Forecast by Market Segment

U.S.A.

Rhinovirus Test Volume and Diagnostics Sales Forecast by

Market

Segment

U.S.A.

Rotavirus Test Volume and Diagnostics Sales Forecast by Market

Segment

U.S.A.

Rubella Test Volume and Diagnostics Sales Forecast by Market

Segment

U.S.A.

Salmonella Test Volume and Diagnostics Sales Forecast by

Market

Segment

U.S.A.

Scleroderma Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

Septicemia Test Volume and Diagnostics Sales Forecast by

Market

Segment

U.S.A.

Shigella Test Volume and Diagnostics Sales Forecast by Market

Segment

U.S.A.

Staphylococci Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

Streptococci Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

Syphilis Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

Toxoplasmosis Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

Trichomonas Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

Tuberculosis Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

Vibrio Test Volume and Diagnostics Sales Forecast by Market

Segment

U.S.A.

Yersinia Test Volume and Diagnostics Sales Forecast by

Market Segment

U.S.A.

AIDS Testing Market Diagnostics Sales by Major

Supplier

U.S.A.

Western Blot Testing Market Diagnostics Sales by

Major Supplier

U.S.A.

Adenovirus Testing Market Diagnostics Sales by

Major Supplier

U.S.A.

Campylobacter Testing Market Diagnostics Sales by

Major Supplier

U.S.A.

Candida Testing Market Diagnostics Sales by Major

Supplier

U.S.A.

Chancroid Testing Market Diagnostics Sales by Major

Supplier

U.S.A.

Chlamydia Testing Market Diagnostics Sales by Major

Supplier

U.S.A.

CMV Testing Market Diagnostics Sales by Major

Supplier

U.S.A.

Echovirus Testing Market Diagnostics Sales by Major

Supplier

U.S.A.

Enterovirus Testing Market Diagnostics Sales by

Major Supplier

U.S.A.

EBV Testing Market Diagnostics Sales by Major

Supplier

U.S.A.

Gonorrhea Testing Market Diagnostics Sales by Major

Supplier

U.S.A.

Hepatitis Testing Market Diagnostics Sales by Major

Supplier

U.S.A.

Hepatitis C Testing Market Diagnostics Sales by

Major Supplier

U.S.A.

Herpes Testing Market Diagnostics Sales by Major

Supplier

U.S.A.

Influenza Testing Market Diagnostics Sales by Major

Supplier

U.S.A.

Legionella Testing Market Diagnostics Sales by

Major Supplier

U.S.A.

Lyme Disease Testing Market Diagnostics Sales by

Major Supplier

U.S.A.

Measles Testing Market Diagnostics Sales by

Major Supplier

U.S.A.

Meningitis Testing Market Diagnostics Sales by Major

Supplier

U.S.A.

Mononucleosis Testing Market Diagnostics Sales by

Major Supplier

U.S.A.

Mumps Testing Market Diagnostics Sales by Major

Supplier

U.S.A.

Mycoplasma Testing Market Diagnostics Sales by

Major Supplier

U.S.A.

Papilloma Testing Market Diagnostics Sales by Major

Supplier

U.S.A.

Pneumonia Testing Market Diagnostics Sales by Major

Supplier

U.S.A.

Rabies Testing Market Diagnostics Sales by Major

Supplier

U.S.A.

RSV Testing Market Diagnostics Sales by Major

Supplier

U.S.A.

Rheumatoid Arthritis Testing Market Diagnostics

Sales by Major Supplier

U.S.A.

Rotavirus Testing Market Diagnostics Sales by Major

Supplier

U.S.A.

Rubella Testing Market Diagnostics Sales by Major

Supplier

U.S.A.

Salmonella Testing Market Diagnostics Sales by

Major Supplier

U.S.A.

Septicemia Testing Market Diagnostics Sales by

Major Supplier

U.S.A.

Shigella Testing Market Diagnostics Sales by Major

Supplier

U.S.A.

Streptococci Testing Market Diagnostics Sales by

Major Supplier

U.S.A.

Syphilis Testing Market Diagnostics Sales by Major

Supplier

U.S.A.

Toxoplasmosis Testing Market Diagnostics Sales by

Major Supplier

U.S.A.

Trichomonas Testing Market Diagnostics Sales by

Major Supplier

U.S.A.

Tuberculosis Testing Market Diagnostics Sales by

Major Supplier

U.S.A.

Infectious Disease Diagnostic Testing Instrumentation

Major Systems Estimated Placements and Installed Base

To order this report:

In Vitro Diagnostic Industry: The 2012 US Infectious Disease Testing Market

More  Market Research Report

Check our  Industry Analysis and Insights

CONTACT
Nicolas Bombourg
Reportlinker
Email: [email protected]

US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker